What is your approach in differentiating IPAF (interstitial pneumonia with autoimmune features) versus "CTD ILD" in patients with serologic abnormalities but do not fulfill criteria for autoimmune disease?
Answer from: at Academic Institution
Even for those of us who work in ILD clinics, this can be a challenging issue. The concept of IPAF (interstitial pneumonia with autoimmune features) was developed in 2015 jointly by the ATS and the ERS for study purposes and as such is somewhat helpful in the clinic. Much like classification criteri...
Comments
at Duke University Medical Center Thank you, very helpful response! It makes sense t...
at University of Washington Agree! Once a patient loses lung tissue we do not ...
at UTMB Health I call these autoimmune ILD. Some patients only ha...
at Uniformed Services University of the Health Sciences (USUHS) @Gregory C. Gardner thanks for the thorough and he...
Thank you, very helpful response! It makes sense t...
Agree! Once a patient loses lung tissue we do not ...
I call these autoimmune ILD. Some patients only ha...
@Gregory C. Gardner thanks for the thorough and he...